Study
Vitamin D Supplementation Does Not Reduce COPD Exacerbations in Older Adults
Research shows that vitamin D supplements do not significantly reduce COPD flare-ups or improve lung function in older adults at risk for respiratory issues.
Summary
In plain language
A recent study explored whether taking vitamin D supplements could help reduce flare-ups of chronic obstructive pulmonary disease (COPD) and improve lung function in older adults. The researchers followed over 3,600 participants, aged 50 and older, who were at risk for respiratory issues. They found that those taking vitamin D did not experience fewer COPD exacerbations or show improved lung function compared to those taking a placebo. For seniors, this means that vitamin D supplements alone may not be effective in managing COPD symptoms. It's important to discuss with healthcare providers whether vitamin D or other treatments might be beneficial for your respiratory health.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
The study was part of a larger trial examining the effects of vitamin D and omega-3 supplements. It involved over 25,000 participants, with a focus on those at risk for respiratory issues, like COPD and asthma. Participants were randomly given either vitamin D supplements or a placebo and followed for five years.
The study found no significant difference in the number of COPD flare-ups between those taking vitamin D and those on a placebo.
Lung function, measured through breathing tests, did not improve with vitamin D supplementation over a two-year period.
Participants were allowed to take up to 800 IU of vitamin D daily from other sources, which may have influenced results.
Discuss with your healthcare provider whether vitamin D supplementation is right for you, especially if you have respiratory concerns.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Vitamin D Supplementation Does Not Reduce COPD Exacerbations in Older Adults
Published October 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored October 22, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study scored well in study design due to its RCT nature and statistical integrity with pre-specified endpoints and adequate power. However, it lacked full transparency in data sharing and did not provide evidence of replication. The conflicts of interest were partially transparent, and the journal quality could not be assessed. The study was relevant to the target population of older adults.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 10.0/10 | |
| Bias control | 6.7/10 | |
| Statistical methods | 10.0/10 | |
| Reporting completeness | 5.0/10 | |
| Conflicts & funding | 7.5/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 10.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
This RCT investigated the effect of vitamin D supplementation on COPD exacerbations and lung function decline in older adults. It found no significant benefit of vitamin D over placebo in reducing COPD exacerbations or improving lung function.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.